Healthcare & Medical Devices Global On demand · 24-48h

Global Laser Treatment Devices for BPH Market Strategic Research Report

Global Laser Treatment Devices for BPH Market Strategic Rese…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Laser Treatment Devices for BPH Market
$6952025
9.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Fixed Type, Removable Type

By Application: Holmium Laser Enucleation of The Prostate (HOLEP), Holmium Laser Ablation of The Prostate (HOLAP), Photoselective Vaporization of The Prostate (PVP)

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Boston Scientific, Endo Pharmaceuticals, KARL STORZ SE & Co. KG, Lumenis, Olympus, Urologix, LISA Laser USA, ProArc Medical, Urovision-Urotech, Teleflex Incorporated, Richard Wolf GmbH, BD (Becton, Dickinson and Company), Biolitec AG, Coloplast Corp, Dornier MedTech, Quanta System, Asclepion Laser Technologies, El.En. Group

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 140 pages
Market size 2025
$695
Million USD
Forecast CAGR
9.5%
2025-2032
Forecast 2032
$1311.8
Projected
Области
5
Asia Pacific · Latin America · MEA · Europe · North America

Обзор

Scope of the Report

The global Laser Treatment Devices for BPH market size is predicted to grow from US$ 695 million in 2025 to US$ 1,303 million in 2032; it is expected to grow at a CAGR of 9.5% from 2026 to 2032.

Laser treatment devices for benign prostatic hyperplasia are minimally invasive surgical systems that use laser energy to ablate, vaporize, or enucleate enlarged prostate tissue, improving urinary flow and reducing lower urinary tract symptoms. These systems are widely used in hospitals and urology centers as alternatives to traditional transurethral resection procedures. In 2025, the average global selling price of BPH laser systems is approximately US$145,000 per unit, with global shipment volume reaching around 4,900 systems. The industry typically maintains a gross margin range of 45%–65%, supported by clinical efficacy advantages, reduced complication rates, shorter hospital stays, and long equipment replacement cycles. The supply chain includes upstream laser sources, optical components, control electronics, and cooling systems; midstream manufacturers focus on system integration, clinical validation, and regulatory approval; downstream users include hospitals, specialized urology clinics, and ambulatory surgery centers.

In 2025, the market for laser treatment devices for BPH continues to expand as aging male populations, increasing awareness of minimally invasive procedures, and favorable clinical outcomes drive adoption worldwide. Laser-based techniques are increasingly preferred due to reduced bleeding risk, shorter catheterization time, and suitability for patients on anticoagulant therapy. Market competition is shaped by laser wavelength selection, power stability, procedural versatility, and clinical evidence accumulation rather than price alone. Manufacturers with broad clinical adoption, strong physician training programs, and regulatory approvals across major regions are better positioned for sustained growth.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Laser Treatment Devices for BPH market?

What factors are driving Laser Treatment Devices for BPH market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Laser Treatment Devices for BPH market opportunities vary by end market size?

How does Laser Treatment Devices for BPH break out by Type, by Application?

This report presents a comprehensive overview of the global Laser Treatment Devices for BPH market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Fixed Type
  • Removable Type

Segment by Laser Type

  • Holmium Laser
  • Green Laser
  • Thulium Laser
  • Diode Laser

Segment by Power Output

  • Low Power (<100W)
  • Medium Power (100–200W)
  • High Power (>200W)

Segment by Application

  • Holmium Laser Enucleation of The Prostate (HOLEP)
  • Holmium Laser Ablation of The Prostate (HOLAP)
  • Photoselective Vaporization of The Prostate (PVP)

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Laser Treatment Devices for BPH market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Holmium Laser Enucleation of The Prostate (HOLEP), Holmium Laser Ablation of The Prostate (HOLAP), Photoselective Vaporization of The Prostate (PVP) evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Laser Treatment Devices for BPH Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$695
2025
Forecast
$1311.8
2032
CAGR
9.5%
2025–2032
Области
5
global
Key companies
Boston ScientificEndo PharmaceuticalsKARL STORZ SE & Co. KGLumenisOlympusUrologixLISA Laser USAProArc Medical
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Fixed TypeRemovable Type
By Application
Holmium Laser Enucleation of The Prostate (HOLEP)Holmium Laser Ablation of The Prostate (HOLAP)Photoselective Vaporization of The Prostate (PVP)

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Fixed Type
  • 3.1.3 Removable Type
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Holmium Laser Enucleation of The Prostate (HOLEP)
  • 4.1.3 Holmium Laser Ablation of The Prostate (HOLAP)
  • 4.1.4 Photoselective Vaporization of The Prostate (PVP)
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Boston Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Endo Pharmaceuticals
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 KARL STORZ SE & Co. KG
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Lumenis
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Olympus
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Urologix
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 LISA Laser USA
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 ProArc Medical
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Urovision-Urotech
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Teleflex Incorporated
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Richard Wolf GmbH
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 BD (Becton, Dickinson and Company)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Biolitec AG
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Coloplast Corp
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Dornier MedTech
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Quanta System
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Asclepion Laser Technologies
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 El.En. Group
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Laser Treatment Devices for BPH market size?
The global Laser Treatment Devices for BPH market is estimated at US$ 695 million in 2025 (base year) and is projected to reach US$ 1.3 billion by 2032.
What growth rate is expected for the Laser Treatment Devices for BPH market through 2032?
The market is expected to grow at a CAGR of 9.5% from 2026 to 2032, expanding from US$ 695 million in 2025 to US$ 1.3 billion in 2032, roughly 1.9 times its base-year value.
How is Laser Treatment Devices for BPH defined?
Laser treatment devices for benign prostatic hyperplasia are minimally invasive surgical systems that use laser energy to ablate, vaporize, or enucleate enlarged prostate tissue, improving urinary flow and reducing lower urinary tract symptoms. These systems are widely used in hospitals and urology centers as alternatives to traditional transurethral resection procedures. In 2025, the average global selling price of BPH laser systems is approximately US$145,000 per unit, with global shipment volume reaching around 4,900 systems.
What are the main segments of the Laser Treatment Devices for BPH market by type?
By type, the market is segmented into Fixed Type and Removable Type.
Which applications drive demand in the Laser Treatment Devices for BPH market?
Key applications covered include Holmium Laser Enucleation of The Prostate (HOLEP), Holmium Laser Ablation of The Prostate (HOLAP) and Photoselective Vaporization of The Prostate (PVP).
Who are the key players in the Laser Treatment Devices for BPH market?
Key players profiled include Boston Scientific, Endo Pharmaceuticals, KARL STORZ SE & Co. KG, Lumenis, Olympus, Urologix, LISA Laser USA and ProArc Medical, among 18 companies covered in total.
Which regions and countries are covered for Laser Treatment Devices for BPH?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Laser Treatment Devices for BPH market?
What factors are driving Laser Treatment Devices for BPH market growth, globally and by region?
Who should buy the Laser Treatment Devices for BPH market report?
The report is intended for manufacturers and solution providers, distributors and end users in Holmium Laser Enucleation of The Prostate (HOLEP), Holmium Laser Ablation of The Prostate (HOLAP) and Photoselective Vaporization of The Prostate (PVP), investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Laser Treatment Devices for BPH market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.